News and Trends 12 May 2023
DiogenX raises €27.5M for “breakthrough” diabetes treatment
DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, has announced the successful completion of a €27.5 million ($30 million) Series A financing round. …